- Elexacaftor: next-generation modulator of the CFTR protein2021 | Second Faculty of Medicine
- Elexacaftor-tezacaftor-ivacaftor for cystic fibrosis with a single Phe508del allele2019 | Second Faculty of Medicine
- Response to elexacaftor/tezacaftor/ivacaftor in intestinal organoids derived from people with cystic fibrosis2022 | Second Faculty of Medicine
- Virtual symposium of experts on the occasion of the official launch of the new medicinal product Kaftrio (R) (ivacaftor / tezakaftor / elexacaftor) on the market in the Czech Republic2021 | Second Faculty of Medicine
- Case report of two adults with F508del/3849+10 kb C > T genotype regaining exocrine pancreatic function following treatment with elexacaftor/tezacaftor/ivacaftorPublication without faculty affiliation
- Elexacaftor-tezacaftor-ivacaftor in patients with cystic fibrosis ineligible for clinical trials: a 24-week observational study2023 | Second Faculty of Medicine
- CFTR protein modulators2019 | Second Faculty of Medicine
- Complex CFTR alleles in the era of CFTR modulator therapy: a case report2023 | Second Faculty of Medicine, Faculty of Medicine in Pilsen, First Faculty of Medicine
- Current possibilities of causal therapy of cystic fibrosis in childhood2021 | Faculty of Medicine in Pilsen